Skip to main content
Oncolys BioPharma Inc. logo

Oncolys BioPharma Inc. — Investor Relations & Filings

Ticker · 4588 ISIN · JP3202170001 T Manufacturing
Filings indexed 83 across all filing types
Latest filing 2019-05-10 Interim / Quarterly Rep…
Country JP Japan
Listing T 4588

About Oncolys BioPharma Inc.

https://www.oncolys.com/en/

Oncolys BioPharma Inc. is a biopharmaceutical company focused on the research and development of breakthrough therapies and diagnostics for cancer. The company's core technology is oncolytic virotherapy, which utilizes viruses to selectively target and destroy cancer cells. Its development pipeline addresses multiple stages of cancer care, spanning from early detection and prognostic testing to loco-regional and systemic treatments. The company aims to develop innovative and effective drugs to meet the needs of patients and healthcare providers in the field of oncology.

Recent filings

Filing Released Lang Actions
四半期報告書-第16期第1四半期(2019/01/01-2019/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains detailed financial statements (balance sheets, etc.) for the first quarter of the 16th fiscal period (Jan 1, 2019 to Mar 31, 2019). According to the definitions, a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements is classified as an Interim/Quarterly Report (IR). Q1 2019
2019-05-10 Japanese
訂正有価証券報告書-第15期(平成30年1月1日-平成30年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Annual Securities Report), which is the standard Japanese equivalent of a 10-K. It contains detailed financial statements, business descriptions, and management information for the fiscal year ending December 31, 2018. The document header explicitly identifies it as a report filed under the Financial Instruments and Exchange Act, and it includes comprehensive financial data, making it a formal Annual Report. FY 2018
2019-04-05 Japanese
訂正四半期報告書-第15期第3四半期(2018/07/01-2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese '四半期報告書' (Quarterly Report) for Oncolys BioPharma Inc., covering the third quarter of the 15th fiscal period (July 1, 2018, to September 30, 2018). It contains detailed financial statements, management analysis, and audit review information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2018
2019-04-05 Japanese
訂正有価証券報告書-第14期(平成29年1月1日-平成29年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Annual Securities Report), which is the Japanese equivalent of a 10-K. It contains detailed financial statements, business descriptions, and management information for the fiscal year ending December 31, 2017. It is a comprehensive annual filing, not an announcement or a summary. FY 2017
2019-04-05 Japanese
訂正四半期報告書-第14期第3四半期(2017/07/01-2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Oncolys BioPharma Inc., covering the third quarter of the 14th fiscal period (July 1, 2017, to September 30, 2017). It contains detailed financial statements, including the balance sheet and income statement, and management analysis. It is not a mere announcement or certification, but the full interim financial report itself. 9M 2017
2019-04-05 Japanese
訂正四半期報告書-第14期第2四半期(2017/04/01-2017/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Oncolys BioPharma Inc., covering the second quarter of the 14th fiscal period (April 1, 2017, to June 30, 2017). It contains detailed financial statements, management analysis of financial results, and business operations. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2017
2019-04-05 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.